Haffner, David,Curry, Ken,Heitzmann, Harold,Applegate, David
申请号：
AU2020204427
公开号：
AU2020204427A1
申请日:
2020.07.02
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
#$%^&*AU2020204427A120200723.pdf#####Abstract An drug delivery ocular implant comprising: an outer shell having an open first end and a closed second end, the outer shell configured to contain at least one drug； a cap configured to be joined with the outer shell at the open first end to form an interior space, the cap having at least one region of drug release, the at least one region of drug release comprising at least one orifice, a permeable or semi-permeable membrane or a coating within the interior space, wherein a permeability of the membrane or the coating is configured to at least partially control the rate of elution of the at least one drug through the at least one region of drug release to a region within an eye. 901/56 N N K1 N N N
